20.2 C
New York
Thursday, July 25, 2024
- Advertisement -

    First Saudi Vaccine for COVID-19 is Set for Clinical Trial

    A research team from the Institute for Research & Medical Consultations (IRMC) affiliated to Imam Abdulrahman Bin Faisal University (IAU) in the Eastern Region of KSA have succeeded in developing the first Saudi vaccine against COVID-19 under the leadership of Dr. Iman Almansour, Assistant Professor at IAU, after carrying out pre-clinical studies and publishing of the research along with all the required approvals.

    The published paper mentions that in the development of the SARS-CoV-2 vaccine candidates encoding the viral spike (S) gene generated using plasmid (P)DNA technology, the researchers demonstrated that eliciting of S-specific antibodies in experimental animals after three doses were successful and promising, the magnitude of binding and neutralizing antibody response with three doses of synthetic codon-optimizing, full-length S ( S.opt.FL) generated robust immune responses. The research has been published in reputed, pharmaceuticals journal. 

    Dr. Iman Almansour, who holds a Ph.D. from the University of Massachusetts, confirmed that this crucial development is a result of one of the research strategic projects funded by the Saudi Ministry of Education in its endeavors and initiatives to combat COVID-19.